The Independent Voice of
European Private Equity

Advanced Search

RD 500: Booming sectors then vs now

Real Deals 28 January 2022

NOW: 

Life sciences

Until recently, this booming sector was one that PE firms tended to avoid, preferring instead to stick to the more traditional healthcare markets where revenue streams are more reliable....

Related Articles

Shake it up

15/05/24

Deal originators part two: crafting a successful buy-and-build

09/05/24

Institutional LPs reducing exposure to PE in the near term: State Street

30/04/24

UK regional dealflow: future growth stars?

29/04/24

Midmarket stars in modest first quarter – Real Deals Data Hub

29/04/24

Alternative asset classes set to see biggest increase in fundraising in 2024

22/04/24